Medicskin Holdings (HKSE:08307) Beta: 0.7168 (As of Aug. 12, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:08307 Medicskin Holdings Ltd HKSE:08307
54 GF Score
Price HK$0.12
GF Value HK$0.18
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Medicskin Holdings Beta?

Medicskin Holdings HKSE:08307 54 Beta is 0.7168 as of Aug. 12, 2026. GuruFocus rates HKSE:08307 with a GF Score™ of 54/100 and a GF Value™ of HK$0.18 (Possible Value Trap). The stock has 4 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-08-12), Medicskin Holdings's Beta is 0.7168.


Medicskin Holdings  (HKSE:08307) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Medicskin Holdings Beta Related Terms


Medicskin Holdings Beta Historical Data

* Premium members only.

The historical data trend for Medicskin Holdings's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicskin Holdings Beta Chart

Medicskin Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.54 0.83

Medicskin Holdings Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.54 0.50 0.83

HKSE:08307 vs HCA, THC, DVA: Beta Comparison

For the Medical Care Facilities subindustry, Medicskin Holdings's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicskin Holdings Beta vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medicskin Holdings's Beta distribution charts can be found below:

* The bar in red indicates where Medicskin Holdings's Beta falls into.


HKSE:08307
54GF Score
Medicskin Holdings Ltd HKSE:08307
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicskin Holdings Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.7168 mean?
Medicskin Holdings (HKSE:08307) has a Beta of 0.7168 as of Aug. 12, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Medicskin Holdings and its competitors.
Is Medicskin Holdings' Beta too high?
Medicskin Holdings' current Beta is 0.7168. Overall, Medicskin Holdings has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medicskin Holdings' Beta compare to HCA and THC?
Medicskin Holdings' Beta of 0.7168 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Medicskin Holdings and its competitors. Medicskin Holdings's current Beta is 0.7168. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicskin Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medicskin Holdings (HKSE:08307) is currently considered Possible Value Trap. The stock's GF Value™ is HK$0.18, compared to a current price of HK$0.12 — trading 31.7% below its estimated fair value. The current Beta is 0.7168. Medicskin Holdings' overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Medicskin Holdings (HKSE:08307), the current Beta is 0.7168 as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medicskin Holdings (HKSE:08307) Overvalued in 2026?

Based on GuruFocus' analysis, Medicskin Holdings stock appears to be undervalued. The current stock price of HK$0.12 is trading 31.7% below its estimated GF Value™ of HK$0.18. GuruFocus considers Medicskin Holdings to be Possible Value Trap.

Key valuation signals for HKSE:08307:

  • Beta: 0.7168
  • GF Value™: HK$0.18 vs. price of HK$0.12 (31.7% below fair value)
  • GF Score™: 54/100 with 4 warning signs

No single metric tells the full story. See the HKSE:08307 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medicskin Holdings Business Description

Address 11 Wing Kut Street, Wing Hang Insurance Building, Unit B, 9th Floor, Hong Kong, HKG
Medicskin Holdings Ltd is a medical skin care service provider. It is engaged in providing services for inter alia, acne, pigmentation, rosacea, dermatitis, eczema and warts, skin rejuvenation, facial sculpturing and body contouring, treatment for acne scars and enlarged pores, removal of undesirable naevi, and hair removal. The company operates through a single segment namely Consultation Service, Prescription and Dispensing Service, and Treatment Services. The company offers services throughout Hong Kong.
54GF Score

Get the complete analysis for HKSE:08307

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.12
Price
HK$0.18
GF Value